The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis
Open accessAbstract
Background: Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods: Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results: For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions: In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Katzman, J. L., Shaham, U., Cloninger, A., Bates, J., Jiang, T., & Kluger, Y. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0482-1 · Cited by 1,995
Toward a Shared Vision for Cancer Genomic Data
Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1607591 · Cited by 1,680
Uno, H., Cai, T., Pencina, M. J., D'Agostino, R. B., & Wei, L. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4154 · Cited by 1,535
SALMON: survival analysis learning with multi-omics neural networks on breast cancer
Huang, Z., Zhan, X., Xiang, S., Johnson, T. S., Helm, B., Yu, C. Y., Zhang, J., Salama, P., Rizkalla, M., Han, Z., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00166 · Cited by 262
Cited by
Multimodal deep learning for biomedical data fusion: a review
Stahlschmidt, S. R., Ulfenborg, B., & Synnergren, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab569 · Cited by 766
“‖zm (see Figure 4b) and used as input to further modeling, such as clustering followed by a classifier for cancer subtyping [45–47], or directly as input to a classifier for multi-class classification or survival analysis [48].”
MethodMultimodal deep learning models for early detection of Alzheimer’s disease stage
Venugopalan, J., Tong, L., Hassanzadeh, H. R., & Wang, M. D. (2021) · Scientific Reports · doi:10.1038/s41598-020-74399-w · Cited by 732
Self-citationA roadmap for multi-omics data integration using deep learning
Kang, M., Ko, E., & Mersha, T. B. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab454 · Cited by 389
Current progress and open challenges for applying deep learning across the biosciences
Sapoval, N., Aghazadeh, A., Nute, M. G., Antunes, D. A., Balaji, A., Baraniuk, R., Barberan, C. J., Dannenfelser, R., Dun, C., Edrisi, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29268-7 · Cited by 359
Deep learning-based approaches for multi-omics data integration and analysis
Ballard, J. L., Wang, Z., Li, W., Shen, L., & Long, Q. (2024) · BioData Mining · doi:10.1186/s13040-024-00391-z · Cited by 258
Metadata
- Authors
- Tong, L., Mitchel, J., Chatlin, K., & Wang, M. D.
- Venue
- BMC Medical Informatics and Decision Making
- Published
- 2020-09-15
- Volume
- 20
- Issue
- 1
- Pages
- 225-225
- ISSN
- 1472-6947 (ISSN-L)
- OpenAlex
- W3085172652
- Cited by
- 158
- References
- 4
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis. https://app.cochat.ai/papers/10.1186/s12911-020-01225-8
- The paper
- Tong, L., Mitchel, J., Chatlin, K., & Wang, M. D. (2020). Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-020-01225-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.